Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I P Gray

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurityI P Gray, P A Cooper, B J Cory, et al.
Lancet (London, England)|July 28, 1990
Cushing's syndrome and medroxyprogesterone acetateA Grenfell, A Rudenski, M Watts, et al.
Clinical Science (London, England : 1979)|September 1, 1995
Beta-cell function in hypopituitary adults before and during growth hormone treatmentS A Beshyah, S V Gelding, C Andres, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1993
Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitusM J Davies, J Metcalfe, I P Gray, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1993
Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose toleranceM J Davies, G Rayman, I P Gray, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1988
Determination of proinsulin intermediates by means of an immunoradiometric method using polyclonal antibodiesT R Zilker, S J Rainbow, C N Hales, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 1994
Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetesS V Gelding, C Andres, R Niththyananthan, et al.
Clinical Endocrinology|March 1, 1995
Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, originS V Gelding, C Andres, R Niththyananthan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1994
Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitusM J Davies, J Metcalfe, J L Day, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1994
Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose toleranceM J Davies, G Rayman, A Grenfell, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurityI P Gray, P A Cooper, B J Cory, et al.
Lancet (London, England)|July 28, 1990
Cushing's syndrome and medroxyprogesterone acetateA Grenfell, A Rudenski, M Watts, et al.
Clinical Science (London, England : 1979)|September 1, 1995
Beta-cell function in hypopituitary adults before and during growth hormone treatmentS A Beshyah, S V Gelding, C Andres, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1993
Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitusM J Davies, J Metcalfe, I P Gray, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1993
Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose toleranceM J Davies, G Rayman, I P Gray, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1988
Determination of proinsulin intermediates by means of an immunoradiometric method using polyclonal antibodiesT R Zilker, S J Rainbow, C N Hales, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 1994
Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetesS V Gelding, C Andres, R Niththyananthan, et al.
Clinical Endocrinology|March 1, 1995
Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, originS V Gelding, C Andres, R Niththyananthan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1994
Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitusM J Davies, J Metcalfe, J L Day, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1994
Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose toleranceM J Davies, G Rayman, A Grenfell, et al.
Pageof 4